# Efficacy and Safety of the Once-Weekly GLP-1 Receptor Agonist Albiglutide Versus Sitagliptin in Patients With Type 2 Diabetes and Renal Impairment: A Randomized Phase III Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-the-once-weekly-glp-1-receptor-agonist-albiglutide-versus/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lawrence A. Leiter,Molly C. Carr,Murray Stewart,Angela R. Jones-Leone,Rhona Scott,Fred Yang,Yehuda Handelsman |
| Citations | 93 |
| DOI | 10.2337/dc13-2855 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2114027444 |
| PMID | 25048383 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Lawrence A. Leiter](https://scholariq.org/researchers/lawrence-a-leiter/)
- [Molly C. Carr](https://scholariq.org/researchers/molly-c-carr/)
- [Fred Yang](https://scholariq.org/researchers/fred-yang/)
- [Murray Stewart](https://scholariq.org/researchers/murray-stewart/)
- [Yehuda Handelsman](https://scholariq.org/researchers/yehuda-handelsman/)

## Paper journal

- [Diabetes Care](https://scholariq.org/journals/diabetes-care/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.